AG
FOLD

Aperio Group’s Amicus Therapeutics FOLD Stock Holding History

Aperio Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.14M Buy
49,436
+585
+1% +$12K ﹤0.01% 1527
2020
Q3 		$690K Buy
48,851
+2,187
+5% +$31.9K ﹤0.01% 1636
2020
Q2 		$704K Buy
46,664
+5,138
+12% +$62.6K ﹤0.01% 1590
2020
Q1 		$384K Sell
41,526
-11,221
-21% -$107K ﹤0.01% 1785
2019
Q4 		$514K Buy
52,747
+26,596
+102% +$243K ﹤0.01% 1783
2019
Q3 		$210K Buy
26,151
+389
+2% +$4.22K ﹤0.01% 2155
2019
Q2 		$322K Buy
25,762
+4,026
+19% +$51.1K ﹤0.01% 1992
2019
Q1 		$296K Buy
21,736
+1,525
+8% +$18.6K ﹤0.01% 2003
2018
Q4 		$194K Buy
20,211
+3,534
+21% +$38.8K ﹤0.01% 2134
2018
Q3 		$202K Buy
16,677
+1,323
+9% +$18.5K ﹤0.01% 2187
2018
Q2 		$240K Sell
15,354
-396
-3% -$5.99K ﹤0.01% 2092
2018
Q1 		$237K Buy
15,750
+77
+0.5% +$1.17K ﹤0.01% 2063
2017
Q4 		$226K Buy
15,673
+347
+2% +$4.77K ﹤0.01% 2096
2017
Q3 		$231K Buy
15,326
+1,340
+10% +$17.7K ﹤0.01% 2058
2017
Q2 		$141K Buy
13,986
+1,663
+13% +$13.4K ﹤0.01% 2149
2017
Q1 		$88K Buy
+12,323
New +$77.9K ﹤0.01% 2116

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aperio Group's FOLD Position: Q4 2020 in Review

Aperio Group increased its Amicus Therapeutics (FOLD) stake by 1.2% in Q4 2020, buying an estimated $12K and bringing the position to 49,436 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Aperio Group first reported a position in FOLD in Q1 2017 and has held it in 16 quarters since. 271 funds tracked by Wall St. Rank hold FOLD as of Q4 2020.

  • Aperio Group held 49,436 shares of Amicus Therapeutics worth $1.14M as of Q4 2020.
  • Aperio Group bought 585 Amicus Therapeutics shares in Q4 2020, an estimated $12K.
  • Amicus Therapeutics made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1527 holding.
  • Aperio Group first reported a position in Amicus Therapeutics in Q1 2017 and has held it in 16 quarters since.
  • 271 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.